Founded in 2005, nContact specializes in creating devices for the endoscopic treatment of arrhythmias, with a focus on atrial fibrillation. Their flagship product, the Numeris Coagulation System with VisiTrax, integrates suction, perfusion, and RF energy to create visible, nonconductive, continuous, bi-atrial lesions on the epicardium of a beating heart. The system is currently indicated for endoscopic coagulation of cardiac tissue in the United States and has received CE Mark approval in Europe for the treatment of atrial fibrillation and atrial flutter. nContact has also initiated IDE clinical studies for the treatment of atrial fibrillation using both open and closed chest procedures.